マーケットレポート詳細

生殖補助医療(ART)の世界市場:2031年予測

Assisted Reproductive Technology Market (Technology: In Vitro Fertilization, Artificial Insemination, Surrogacy, and Others; and Procedure: Frozen Donor, Frozen Non-donor, Fresh Donor, Fresh Non-donor, and Embryo Banking) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版元:Transparency Market Research   出版元について
発行年:2023年12月
定価 :Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文189ページになります。
商品コード:TMR161

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

生殖補助医療(ART)の世界市場規模は2022年で259億ドル、2031年に586億ドル、市場の平均年成長率は9.4%に増で推移する見通しです。

当レポートでは、生殖補助医療(ART)の市場予測-2031年、各種セグメント別市場分析(技術別、エンドユーザー別、国地域別、等)、COVID-19の影響、競合状況、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

■生殖補助医療(ART)の世界市場予測2017-2031年

・市場規模(US$)

■技術別、市場-2031年

体外受精
・顕微授精(ICSI)
・着床前遺伝子検査(PGD)

人工授精
・子宮腔内精子注入法(IUI)
・子宮頸管内人工授精(ICI)
・その他

代理出産
その他
※(市場規模US$)

■手続き別、市場-2031年

凍結ドナー
凍結非ドナー
新鮮ドナー
新鮮非ドナー
胚バンク
※(市場規模US$)

■エンドユーザー別、市場-2031年

不妊治療クリニック
病院
その他
※(市場規模US$)

■主要国地域別市場-2031年

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析

市場ダイナミクス(促進要因、障壁、機会)
パイプライン分析
COVID-19の影響
競合状況
市場シェア分析
SWOT分析

■生殖補助医療(ART)の主要企業プロフィール動向

Merck KGaA
CooperSurgical, Inc.
FUJIFILM Irvine Scientific.
Vitrolife AB
Hamilton Thorne, Inc.
株式会社ニコン
Nidacon International AB
Laboratoire CCD
Esco Micro Pte. Ltd.

(全189頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1. Preface

    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology
3. Executive Summary: Global Assisted Reproductive Technology Market
4. Market Overview

    4.1. Introduction
        4.1.1. Technology Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Assisted Reproductive Technology Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Pipeline Analysis
    5.2. Key Technology/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry

6. Global Assisted Reproductive Technology Market Analysis and Forecast, by Technology

    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Technology, 2017–2031
        6.3.1. In Vitro Fertilization
            6.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
            6.3.1.2. Preimplantation Genetic Diagnosis (PGD)
        6.3.2. Artificial Insemination
            6.3.2.1. Intrauterine Insemination (IUI)
            6.3.2.2. Intracervical Insemination (ICI)
            6.3.2.3. Others
        6.3.3. Surrogacy
        6.3.4. Others
    6.4. Market Attractiveness Analysis, by Technology

7. Global Assisted Reproductive Technology Market Analysis and Forecast, by Procedure

    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Procedure, 2017–2031
        7.3.1. Frozen Donor
        7.3.2. Frozen Non-donor
        7.3.3. Fresh Donor
        7.3.4. Fresh Non-donor
        7.3.5. Embryo Banking
    7.4. Market Attractiveness Analysis, by Procedure

8. Global Assisted Reproductive Technology Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Fertility Clinics
        8.3.2. Hospitals
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by End-user

9. Global Assisted Reproductive Technology Market Analysis and Forecast, by Region

    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region

10. North America Assisted Reproductive Technology Market Analysis and Forecast

    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Technology, 2017–2031
        10.3.1. In Vitro Fertilization
            10.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
            10.3.1.2. Preimplantation Genetic Diagnosis (PGD)
        10.3.2. Artificial Insemination
            10.3.2.1. Intrauterine Insemination (IUI)
            10.3.2.2. Intracervical Insemination (ICI)
            10.3.2.3. Others
        10.3.3. Surrogacy
        10.3.4. Others
    10.4. Market Value Forecast, by Procedure, 2017–2031
        10.4.1. Frozen Donor
        10.4.2. Frozen Non-donor
        10.4.3. Fresh Donor
        10.4.4. Fresh Non-donor
        10.4.5. Embryo Banking
    10.5. Market Value Forecast, by End-user, 2017–2031
        10.5.1. Fertility Clinics
        10.5.2. Hospitals
        10.5.3. Others
    10.6. Market Value Forecast, by Country, 2017–2031
        10.6.1. U.S.
        10.6.2. Canada
    10.7. Market Attractiveness Analysis
        10.7.1. By Technology
        10.7.2. By Procedure
        10.7.3. By End-user
        10.7.4. By Country

11. Europe Assisted Reproductive Technology Market Analysis and Forecast

    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Technology, 2017–2031
        11.3.1. In Vitro Fertilization
            11.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
            11.3.1.2. Preimplantation Genetic Diagnosis (PGD)
        11.3.2. Artificial Insemination
            11.3.2.1. Intrauterine Insemination (IUI)
            11.3.2.2. Intracervical Insemination (ICI)
            11.3.2.3. Others
        11.3.3. Surrogacy
        11.3.4. Others
    11.4. Market Value Forecast, by Procedure, 2017–2031
        11.4.1. Frozen Donor
        11.4.2. Frozen Non-donor
        11.4.3. Fresh Donor
        11.4.4. Fresh Non-donor
        11.4.5. Embryo Banking
    11.5. Market Value Forecast, by End-user, 2017–2031
        11.5.1. Fertility Clinics
        11.5.2. Hospitals
        11.5.3. Others
    11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.6.1. Germany
        11.6.2. U.K.
        11.6.3. France
        11.6.4. Italy
        11.6.5. Spain
        11.6.6. Rest of Europe
    11.7. Market Attractiveness Analysis
        11.7.1. By Technology
        11.7.2. By Procedure
        11.7.3. By End-user
        11.7.4. By Country/Sub-region

12. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast

    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Technology, 2017–2031
        12.3.1. In Vitro Fertilization
            12.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
            12.3.1.2. Preimplantation Genetic Diagnosis (PGD)
        12.3.2. Artificial Insemination
            12.3.2.1. Intrauterine Insemination (IUI)
            12.3.2.2. Intracervical Insemination (ICI)
            12.3.2.3. Others
        12.3.3. Surrogacy
        12.3.4. Others
    12.4. Market Value Forecast, by Procedure, 2017–2031
        12.4.1. Frozen Donor
        12.4.2. Frozen Non-donor
        12.4.3. Fresh Donor
        12.4.4. Fresh Non-donor
        12.4.5. Embryo Banking
    12.5. Market Value Forecast, by End-user, 2017–2031
        12.5.1. Fertility Clinics
        12.5.2. Hospitals
        12.5.3. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. China
        12.6.2. Japan
        12.6.3. India
        12.6.4. Australia & New Zealand
        12.6.5. Rest of Asia Pacific
    12.7. Market Attractiveness Analysis
        12.7.1. By Technology
        12.7.2. By Procedure
        12.7.3. By End-user
        12.7.4. By Country/Sub-region

13. Latin America Assisted Reproductive Technology Market Analysis and Forecast

    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Technology, 2017–2031
        13.3.1. In Vitro Fertilization
            13.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
            13.3.1.2. Preimplantation Genetic Diagnosis (PGD)
        13.3.2. Artificial Insemination
            13.3.2.1. Intrauterine Insemination (IUI)
            13.3.2.2. Intracervical Insemination (ICI)
            13.3.2.3. Others
        13.3.3. Surrogacy
        13.3.4. Others
    13.4. Market Value Forecast, by Procedure, 2017–2031
        13.4.1. Frozen Donor
        13.4.2. Frozen Non-donor
        13.4.3. Fresh Donor
        13.4.4. Fresh Non-donor
        13.4.5. Embryo Banking
    13.5. Market Value Forecast, by End-user, 2017–2031
        13.5.1. Fertility Clinics
        13.5.2. Hospitals
        13.5.3. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. Brazil
        13.6.2. Mexico
        13.6.3. Rest of Latin America
    13.7. Market Attractiveness Analysis
        13.7.1. By Technology
        13.7.2. By Procedure
        13.7.3. By End-user
        13.7.4. By Country/Sub-region

14. Middle East & Africa Assisted Reproductive Technology Market Analysis and Forecast

    14.1. Introduction
    14.2. Key Findings
    14.3. Market Value Forecast, by Technology, 2017–2031
        14.3.1. In Vitro Fertilization
            14.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
            14.3.1.2. Preimplantation Genetic Diagnosis (PGD)
        14.3.2. Artificial Insemination
            14.3.2.1. Intrauterine Insemination (IUI)
            14.3.2.2. Intracervical Insemination (ICI)
            14.3.2.3. Others
        14.3.3. Surrogacy
        14.3.4. Others
    14.4. Market Value Forecast, by Procedure, 2017–2031
        14.4.1. Frozen Donor
        14.4.2. Frozen Non-donor
        14.4.3. Fresh Donor
        14.4.4. Fresh Non-donor
        14.4.5. Embryo Banking
    14.5. Market Value Forecast, by End-user, 2017–2031
        14.5.1. Fertility Clinics
        14.5.2. Hospitals
        14.5.3. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. GCC Countries
        14.6.2. South Africa
        14.6.3. Rest of Middle East & Africa
    14.7. Market Attractiveness Analysis
        14.7.1. By Technology
        14.7.2. By Procedure
        14.7.3. By End-user
        14.7.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
    15.2. Market Share Analysis, by Company (2022)
    15.3. Company Profiles
        15.3.1. Merck KGaA
            15.3.1.1. Company Overview
            15.3.1.2. Technology Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. CooperSurgical, Inc.
            15.3.2.1. Company Overview
            15.3.2.2. Technology Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. FUJIFILM Irvine Scientific
            15.3.3.1. Company Overview
            15.3.3.2. Technology Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. Vitrolife AB
            15.3.4.1. Company Overview
            15.3.4.2. Technology Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. Hamilton Thorne, Inc.
            15.3.5.1. Company Overview
            15.3.5.2. Technology Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. Nikon Corporation
            15.3.6.1. Company Overview
            15.3.6.2. Technology Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Financial Overview
            15.3.6.5. Strategic Overview
        15.3.7. Nidacon International AB
            15.3.7.1. Company Overview
            15.3.7.2. Technology Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Financial Overview
            15.3.7.5. Strategic Overview
        15.3.8. Laboratoire CCD
            15.3.8.1. Company Overview
            15.3.8.2. Technology Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Financial Overview
            15.3.8.5. Strategic Overview
        15.3.9. Esco Micro Pte. Ltd.
            15.3.9.1. Company Overview
            15.3.9.2. Technology Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Financial Overview
            15.3.9.5. Strategic Overview

List of Tables

Table 01: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 02: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 03: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 07: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 08: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 11: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 12: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 15: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 16: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 19: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 20: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 23: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031

Table 24: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Assisted Reproductive Technology Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031

Figure 02: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Technology, 2022

Figure 03: Global Assisted Reproductive Technology Market Value Share, by Technology, 2022

Figure 04: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Procedure, 2022

Figure 05: Global Assisted Reproductive Technology Market Value Share, by Procedure, 2022

Figure 06: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by End-user, 2022

Figure 07: Global Assisted Reproductive Technology Market Value Share, by End-user, 2022

Figure 08: Global Assisted Reproductive Technology Market Value Share, by Region, 2022

Figure 09: Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, 2023–2031

Figure 10: Global Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

Figure 11: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031

Figure 12: Global Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 13: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031

Figure 14: Global Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

Figure 15: Global Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2022-2031

Figure 16: Global Assisted Reproductive Technology Market Value Share Analysis, by Region, 2022 and 2031

Figure 17: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Region, 2022-2031

Figure 18: North America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 19: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Country, 2023–2031

Figure 20: North America Assisted Reproductive Technology Market Value Share Analysis, by Country, 2022 and 2031

Figure 21: North America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

Figure 22: North America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 23: North America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

Figure 24: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

Figure 25: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 26: North America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

Figure 27: Europe Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 28: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 29: Europe Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 30: Europe Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

Figure 31: Europe Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 32: Europe Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

Figure 33: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

Figure 34: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 35: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

Figure 36: Asia Pacific Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 37: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 38: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 39: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

Figure 40: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 41: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

Figure 42: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

Figure 43: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 44: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

Figure 45: Latin America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 46: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 47: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 48: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

Figure 49: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 50: Latin America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

Figure 51: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

Figure 52: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 53: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

Figure 54: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 55: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 56: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 57: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031

Figure 58: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031

Figure 59: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031

Figure 60: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031

Figure 61: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031

Figure 62: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031

△ 一番上に戻る